genome-wide epi/transcriptome mapping

Advanced diagnostics for cardiovascular diseases, including COVID-19-associated disease, are discussed with a focus on the role of inflammation in cardiomyopathies and arrhythmias.

First, we discuss the emerging clinical relevance of advanced diagnostics for cardiovascular diseases, including those associated with COVID-19-with a focus on the role of inflammation in cardiomyopathies and arrhythmias.

The review emphasizes that emotional stress acting through defined brain regions strongly influences viral and cardiovascular disorders.

This latter line of investigation emphasizes the strength of influence of emotional stress-acting through defined brain regions-upon viral and cardiovascular disorders.

The review states that newly identified immunological interactions at organ and system levels affect cardiovascular pathogenesis, including intestinal-system influences moving toward therapeutic exploitation.

Second, we consider newly identified immunological interactions at organ and system levels which affect cardiovascular pathogenesis. Thus, studies into immune influences arising from the intestinal system are moving towards therapeutic exploitation.

The review focuses on selected cardiovascular immunology studies that use advanced molecular-genetic methods including genome-wide epi/transcriptome mapping, variant scanning, optogenetics, and chemogenetics.

Here, we specifically focus on selected studies taking advantage of advanced state-of-the-art molecular genetic methods ranging from genome-wide epi/transcriptome mapping and variant scanning to optogenetics and chemogenetics.

Powerful new research tools have enabled novel insight into brain-immune system interactions at unprecedented resolution.

Further, powerful new research tools have enabled novel insight into brain-immune system interactions at unprecedented resolution.

Several challenges remain before the full impact of these new findings reaches the clinical arena.

Several challenges need to be overcome before the full impact of these far-reaching new findings will hit the clinical arena.

Advanced diagnostics for cardiovascular diseases, including COVID-19-associated disease, are discussed with a focus on the role of inflammation in cardiomyopathies and arrhythmias.

First, we discuss the emerging clinical relevance of advanced diagnostics for cardiovascular diseases, including those associated with COVID-19-with a focus on the role of inflammation in cardiomyopathies and arrhythmias.

Source: Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets

The review states that newly identified immunological interactions at organ and system levels affect cardiovascular pathogenesis, including intestinal-system influences moving toward therapeutic exploitation.

Second, we consider newly identified immunological interactions at organ and system levels which affect cardiovascular pathogenesis. Thus, studies into immune influences arising from the intestinal system are moving towards therapeutic exploitation.

Source: Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets

The review focuses on selected cardiovascular immunology studies that use advanced molecular-genetic methods including genome-wide epi/transcriptome mapping, variant scanning, optogenetics, and chemogenetics.

Here, we specifically focus on selected studies taking advantage of advanced state-of-the-art molecular genetic methods ranging from genome-wide epi/transcriptome mapping and variant scanning to optogenetics and chemogenetics.

Source: Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets

Several challenges remain before the full impact of these new findings reaches the clinical arena.

Several challenges need to be overcome before the full impact of these far-reaching new findings will hit the clinical arena.

Source: Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets